Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding even ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
Cardiovascular diseases are the leading cause of death globally and in Brazil. The provision of quality healthcare faces ...
Excessive supraventricular ectopic activity (ESVEA) in the acute phase of ischemic stroke or transient ischemic attack (TIA) ...
Garmin GRMN has been successful in significant strides while demonstrating its ability to expand its market presence and ...
The company announced that the ECG app is now available in the EU and Australia. As you might expect, the ECG app lets you ...
The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...
Garmin (NYSE: GRMN) today announced the ECG App is now available to customers in Australia and the European Union with a ...
Garmin (GRMN) announced the ECG App is now available to customers in Australia and the European Union with a compatible Garmin smartwatch, ...
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...
A Fitbit got a reporter to see his doctor — and ultimately go under the knife. Are wearables the next wave in heart health?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback